COVID-19 vaccination is associated with attenuation of inflammatory responses during breakthrough disease [small RNA-Seq]
Ontology highlight
ABSTRACT: A subset of individualsenrolledina randomised controlled trial ofChAdOx1 nCoV-19 and received either ChAdOx1 COVID-19 or control MenACWY vaccine whoexperienced COVID-19-associated symptoms were evaluated using multi-omictechnologies. Participants were selected to represent symptomatic individuals with and without COVID-19 as determined by a nucleic acid amplification test (NAAT) for stage 1 and only NAAT+ve for stage 2 of the study.
ORGANISM(S): Homo sapiens
PROVIDER: GSE228841 | GEO | 2024/03/04
REPOSITORIES: GEO
ACCESS DATA